Lauren Vanderlinden
Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 12 | 2026 | 683 | 2.230 |
Why?
| | Islets of Langerhans | 10 | 2026 | 833 | 1.610 |
Why?
| | Autoimmunity | 13 | 2026 | 927 | 1.590 |
Why?
| | Diabetes Mellitus, Type 1 | 16 | 2026 | 3890 | 1.090 |
Why?
| | Alcohol Drinking | 6 | 2018 | 826 | 0.930 |
Why?
| | Rats, Inbred Strains | 4 | 2019 | 321 | 0.620 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2022 | 239 | 0.610 |
Why?
| | Quantitative Trait Loci | 5 | 2020 | 374 | 0.610 |
Why?
| | Smoking | 1 | 2025 | 1472 | 0.550 |
Why?
| | Quantitative Trait, Heritable | 2 | 2017 | 118 | 0.520 |
Why?
| | Autoantibodies | 7 | 2026 | 1504 | 0.520 |
Why?
| | Arthritis, Rheumatoid | 3 | 2024 | 1169 | 0.520 |
Why?
| | Genetic Predisposition to Disease | 8 | 2024 | 2365 | 0.500 |
Why?
| | Gene Regulatory Networks | 4 | 2019 | 320 | 0.480 |
Why?
| | Genome-Wide Association Study | 6 | 2024 | 1407 | 0.470 |
Why?
| | Brain | 8 | 2022 | 2941 | 0.460 |
Why?
| | Seroconversion | 3 | 2026 | 49 | 0.440 |
Why?
| | Darkness | 1 | 2015 | 26 | 0.440 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 2 | 2025 | 88 | 0.430 |
Why?
| | Alcoholism | 3 | 2014 | 817 | 0.380 |
Why?
| | Oxylipins | 3 | 2023 | 47 | 0.370 |
Why?
| | Vitamin D | 2 | 2026 | 400 | 0.330 |
Why?
| | Epigenesis, Genetic | 6 | 2026 | 685 | 0.320 |
Why?
| | Circadian Rhythm | 1 | 2015 | 514 | 0.310 |
Why?
| | Phenotype | 2 | 2015 | 3164 | 0.300 |
Why?
| | Polymorphism, Single Nucleotide | 6 | 2025 | 2147 | 0.300 |
Why?
| | Body Mass Index | 4 | 2025 | 2438 | 0.290 |
Why?
| | Male | 33 | 2026 | 72406 | 0.280 |
Why?
| | Child | 19 | 2026 | 22657 | 0.270 |
Why?
| | Systems Biology | 2 | 2019 | 72 | 0.270 |
Why?
| | Algorithms | 3 | 2024 | 1839 | 0.260 |
Why?
| | CpG Islands | 3 | 2023 | 165 | 0.260 |
Why?
| | Longitudinal Studies | 5 | 2026 | 2947 | 0.250 |
Why?
| | Case-Control Studies | 9 | 2026 | 3608 | 0.240 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2021 | 259 | 0.240 |
Why?
| | Genotype | 4 | 2025 | 1835 | 0.230 |
Why?
| | Adolescent | 14 | 2026 | 22453 | 0.230 |
Why?
| | Humans | 42 | 2026 | 144957 | 0.220 |
Why?
| | Female | 29 | 2026 | 78376 | 0.220 |
Why?
| | Diet | 3 | 2021 | 1275 | 0.220 |
Why?
| | Child, Preschool | 13 | 2026 | 11799 | 0.210 |
Why?
| | Metabolomics | 5 | 2021 | 727 | 0.210 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2021 | 49 | 0.200 |
Why?
| | Disease Progression | 4 | 2026 | 2852 | 0.200 |
Why?
| | Gene Expression Profiling | 4 | 2021 | 1786 | 0.200 |
Why?
| | Mice, Inbred Strains | 2 | 2015 | 397 | 0.200 |
Why?
| | Ethanol | 2 | 2018 | 627 | 0.190 |
Why?
| | Extracellular Matrix | 2 | 2021 | 553 | 0.190 |
Why?
| | Rats | 9 | 2019 | 5614 | 0.190 |
Why?
| | Adiposity | 2 | 2017 | 543 | 0.190 |
Why?
| | Animals | 19 | 2022 | 38109 | 0.180 |
Why?
| | Biomarkers, Tumor | 2 | 2021 | 1322 | 0.180 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 68 | 0.170 |
Why?
| | Pregnancy | 6 | 2025 | 7191 | 0.170 |
Why?
| | Single-Cell Analysis | 1 | 2024 | 359 | 0.170 |
Why?
| | Heart Murmurs | 1 | 2021 | 14 | 0.170 |
Why?
| | Lipid Metabolism | 3 | 2019 | 528 | 0.170 |
Why?
| | Propensity Score | 1 | 2023 | 367 | 0.170 |
Why?
| | Diabetes, Gestational | 1 | 2025 | 321 | 0.170 |
Why?
| | Vitamins | 1 | 2022 | 178 | 0.170 |
Why?
| | Risk Factors | 7 | 2023 | 10792 | 0.160 |
Why?
| | Twins, Monozygotic | 1 | 2021 | 134 | 0.160 |
Why?
| | Diseases in Twins | 1 | 2021 | 115 | 0.160 |
Why?
| | Hyaluronan Receptors | 1 | 2021 | 102 | 0.160 |
Why?
| | B-Lymphocytes | 1 | 2026 | 877 | 0.160 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2025 | 675 | 0.160 |
Why?
| | Neutrophils | 1 | 2026 | 1134 | 0.160 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2020 | 15 | 0.160 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 149 | 0.150 |
Why?
| | Receptors, Androgen | 1 | 2021 | 153 | 0.150 |
Why?
| | Phospholipids | 1 | 2021 | 213 | 0.150 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 758 | 0.150 |
Why?
| | Anthracenes | 1 | 2019 | 31 | 0.150 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2021 | 220 | 0.150 |
Why?
| | Drosophila | 1 | 2020 | 166 | 0.150 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 106 | 0.150 |
Why?
| | Eicosanoids | 1 | 2019 | 58 | 0.140 |
Why?
| | Fluorenes | 1 | 2019 | 46 | 0.140 |
Why?
| | Ventricular Remodeling | 1 | 2021 | 276 | 0.140 |
Why?
| | Drosophila Proteins | 1 | 2020 | 212 | 0.140 |
Why?
| | Scoliosis | 1 | 2021 | 224 | 0.140 |
Why?
| | Mice | 9 | 2022 | 18365 | 0.140 |
Why?
| | Metabolic Clearance Rate | 1 | 2018 | 115 | 0.140 |
Why?
| | Unsupervised Machine Learning | 1 | 2018 | 22 | 0.140 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 120 | 0.140 |
Why?
| | Food Hypersensitivity | 1 | 2020 | 164 | 0.140 |
Why?
| | Cohort Studies | 3 | 2026 | 5965 | 0.130 |
Why?
| | Hippocampus | 2 | 2022 | 967 | 0.130 |
Why?
| | Endocrine Disruptors | 1 | 2018 | 45 | 0.130 |
Why?
| | Phthalic Acids | 1 | 2018 | 51 | 0.130 |
Why?
| | Central Amygdaloid Nucleus | 1 | 2017 | 3 | 0.130 |
Why?
| | Insulin | 4 | 2025 | 2507 | 0.130 |
Why?
| | GABA Modulators | 1 | 2017 | 11 | 0.130 |
Why?
| | CD24 Antigen | 1 | 2017 | 18 | 0.130 |
Why?
| | Fatty Acids | 2 | 2017 | 452 | 0.130 |
Why?
| | Health Status | 1 | 2023 | 836 | 0.130 |
Why?
| | Genetic Association Studies | 2 | 2020 | 373 | 0.130 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 321 | 0.130 |
Why?
| | Prospective Studies | 4 | 2023 | 7997 | 0.130 |
Why?
| | Insulin Resistance | 1 | 2025 | 1241 | 0.120 |
Why?
| | Transcriptome | 3 | 2018 | 1046 | 0.120 |
Why?
| | Multifactorial Inheritance | 1 | 2018 | 203 | 0.120 |
Why?
| | Voltage-Gated Sodium Channels | 1 | 2016 | 5 | 0.120 |
Why?
| | Cross-Sectional Studies | 3 | 2023 | 5872 | 0.120 |
Why?
| | Receptors, GABA-A | 1 | 2017 | 138 | 0.120 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2017 | 191 | 0.120 |
Why?
| | Maternal Exposure | 1 | 2018 | 213 | 0.120 |
Why?
| | Seizures | 1 | 2020 | 477 | 0.120 |
Why?
| | Phenylurea Compounds | 1 | 2016 | 112 | 0.110 |
Why?
| | Anxiety | 1 | 2022 | 1110 | 0.110 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2015 | 19 | 0.110 |
Why?
| | Microarray Analysis | 1 | 2015 | 117 | 0.110 |
Why?
| | Quinolines | 1 | 2016 | 193 | 0.110 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2021 | 1462 | 0.110 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2015 | 550 | 0.110 |
Why?
| | Birth Weight | 1 | 2017 | 522 | 0.110 |
Why?
| | Principal Component Analysis | 1 | 2015 | 198 | 0.100 |
Why?
| | Neuralgia | 1 | 2016 | 146 | 0.100 |
Why?
| | Prognosis | 4 | 2026 | 4293 | 0.100 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 228 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2584 | 0.100 |
Why?
| | Cell Nucleus | 1 | 2017 | 619 | 0.100 |
Why?
| | Obesity | 2 | 2017 | 3082 | 0.100 |
Why?
| | Follow-Up Studies | 4 | 2026 | 5417 | 0.100 |
Why?
| | Infant | 7 | 2024 | 10039 | 0.100 |
Why?
| | Cell Proliferation | 2 | 2021 | 2499 | 0.100 |
Why?
| | Genetic Variation | 1 | 2019 | 984 | 0.100 |
Why?
| | Behavior, Addictive | 1 | 2014 | 88 | 0.100 |
Why?
| | Molecular Targeted Therapy | 1 | 2016 | 434 | 0.100 |
Why?
| | Species Specificity | 1 | 2014 | 574 | 0.100 |
Why?
| | Adenylyl Cyclases | 1 | 2012 | 60 | 0.090 |
Why?
| | Gene Expression | 1 | 2017 | 1490 | 0.090 |
Why?
| | Choice Behavior | 1 | 2014 | 178 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 906 | 0.090 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2012 | 81 | 0.090 |
Why?
| | Ibuprofen | 1 | 2012 | 84 | 0.090 |
Why?
| | Pediatrics | 1 | 2020 | 1115 | 0.090 |
Why?
| | Neurons | 2 | 2020 | 1642 | 0.090 |
Why?
| | Mammary Glands, Animal | 1 | 2012 | 128 | 0.090 |
Why?
| | Lipocalin 1 | 1 | 2011 | 2 | 0.090 |
Why?
| | Placenta | 1 | 2018 | 780 | 0.090 |
Why?
| | Sequence Analysis, RNA | 2 | 2024 | 442 | 0.080 |
Why?
| | Base Sequence | 1 | 2015 | 2191 | 0.080 |
Why?
| | Blastocyst | 1 | 2011 | 47 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 4 | 2020 | 2540 | 0.080 |
Why?
| | Models, Genetic | 1 | 2013 | 536 | 0.080 |
Why?
| | Culture Media | 1 | 2011 | 161 | 0.080 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 74 | 0.080 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 76 | 0.080 |
Why?
| | Aneuploidy | 1 | 2011 | 91 | 0.080 |
Why?
| | RNA, Long Noncoding | 1 | 2012 | 178 | 0.080 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2931 | 0.080 |
Why?
| | Pediatric Obesity | 1 | 2017 | 638 | 0.080 |
Why?
| | Postpartum Period | 1 | 2012 | 365 | 0.070 |
Why?
| | Liver | 1 | 2018 | 1888 | 0.070 |
Why?
| | Prenatal Diagnosis | 1 | 2011 | 195 | 0.070 |
Why?
| | Sex Factors | 1 | 2015 | 2114 | 0.070 |
Why?
| | Asthma | 1 | 2020 | 1768 | 0.070 |
Why?
| | Tandem Mass Spectrometry | 3 | 2021 | 577 | 0.070 |
Why?
| | Mice, Nude | 2 | 2021 | 688 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2021 | 919 | 0.070 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 1325 | 0.060 |
Why?
| | Rats, Inbred BN | 2 | 2018 | 55 | 0.060 |
Why?
| | RNA, Messenger | 1 | 2014 | 2832 | 0.060 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2021 | 930 | 0.060 |
Why?
| | Signal Transduction | 1 | 2019 | 5233 | 0.060 |
Why?
| | Age of Onset | 1 | 2026 | 551 | 0.050 |
Why?
| | Glucose Tolerance Test | 1 | 2025 | 361 | 0.050 |
Why?
| | Monte Carlo Method | 1 | 2024 | 155 | 0.050 |
Why?
| | Biomarkers | 3 | 2026 | 4275 | 0.050 |
Why?
| | Proteomics | 1 | 2011 | 1195 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 82 | 0.050 |
Why?
| | Body Height | 1 | 2024 | 202 | 0.050 |
Why?
| | Colitis, Ulcerative | 1 | 2024 | 148 | 0.050 |
Why?
| | Up-Regulation | 2 | 2019 | 852 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2025 | 612 | 0.050 |
Why?
| | Biological Specimen Banks | 1 | 2023 | 103 | 0.040 |
Why?
| | Ascorbic Acid | 1 | 2023 | 180 | 0.040 |
Why?
| | Epitopes | 1 | 2023 | 485 | 0.040 |
Why?
| | Selection Bias | 1 | 2021 | 38 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2020 | 2050 | 0.040 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 54 | 0.040 |
Why?
| | Linoleic Acid | 1 | 2021 | 44 | 0.040 |
Why?
| | Photoreceptor Cells, Invertebrate | 1 | 2020 | 4 | 0.040 |
Why?
| | Arachidonic Acid | 1 | 2021 | 101 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 165 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 83 | 0.040 |
Why?
| | Apoptosis | 2 | 2021 | 2430 | 0.040 |
Why?
| | Probability | 1 | 2021 | 312 | 0.040 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 48 | 0.040 |
Why?
| | Bias | 1 | 2021 | 202 | 0.040 |
Why?
| | Colorado | 2 | 2023 | 4564 | 0.040 |
Why?
| | Kainic Acid | 1 | 2020 | 33 | 0.040 |
Why?
| | Body Weight | 1 | 2024 | 978 | 0.040 |
Why?
| | Young Adult | 3 | 2026 | 14126 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 592 | 0.040 |
Why?
| | Inflammation | 2 | 2024 | 2880 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2020 | 197 | 0.040 |
Why?
| | Fetal Blood | 1 | 2021 | 342 | 0.040 |
Why?
| | Group IV Phospholipases A2 | 1 | 2019 | 46 | 0.040 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2020 | 142 | 0.040 |
Why?
| | Chimera | 1 | 2019 | 61 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 598 | 0.040 |
Why?
| | Molecular Weight | 1 | 2019 | 327 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 481 | 0.040 |
Why?
| | Rats, Transgenic | 1 | 2018 | 18 | 0.040 |
Why?
| | Rats, Inbred SHR | 1 | 2018 | 37 | 0.040 |
Why?
| | Cyclooxygenase 2 | 1 | 2019 | 165 | 0.040 |
Why?
| | Precision Medicine | 1 | 2023 | 458 | 0.030 |
Why?
| | Receptors, AMPA | 1 | 2020 | 147 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2019 | 249 | 0.030 |
Why?
| | Interleukins | 1 | 2020 | 248 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 266 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 32 | 0.030 |
Why?
| | Radioligand Assay | 1 | 2017 | 37 | 0.030 |
Why?
| | Breast Feeding | 1 | 2021 | 448 | 0.030 |
Why?
| | Adult | 4 | 2026 | 40506 | 0.030 |
Why?
| | Whole Genome Sequencing | 1 | 2019 | 183 | 0.030 |
Why?
| | Muscle Cells | 1 | 2017 | 42 | 0.030 |
Why?
| | Pregnancy Trimester, First | 1 | 2018 | 136 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2019 | 768 | 0.030 |
Why?
| | Electron Transport | 1 | 2017 | 118 | 0.030 |
Why?
| | Xenopus laevis | 1 | 2017 | 105 | 0.030 |
Why?
| | Collagen | 1 | 2020 | 456 | 0.030 |
Why?
| | Carnitine | 1 | 2017 | 90 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2017 | 91 | 0.030 |
Why?
| | Models, Animal | 1 | 2019 | 392 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1184 | 0.030 |
Why?
| | Mitochondrial Diseases | 1 | 2017 | 93 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 444 | 0.030 |
Why?
| | Muscle Development | 1 | 2017 | 116 | 0.030 |
Why?
| | Protein Subunits | 1 | 2017 | 226 | 0.030 |
Why?
| | Sodium Channel Blockers | 1 | 2016 | 24 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 846 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1253 | 0.030 |
Why?
| | Cricetulus | 1 | 2016 | 118 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2017 | 334 | 0.030 |
Why?
| | CHO Cells | 1 | 2016 | 171 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2024 | 1177 | 0.030 |
Why?
| | Cricetinae | 1 | 2016 | 304 | 0.030 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2017 | 181 | 0.030 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2017 | 193 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2017 | 6434 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2017 | 509 | 0.030 |
Why?
| | Databases, Nucleic Acid | 1 | 2015 | 39 | 0.030 |
Why?
| | Blood Glucose | 1 | 2025 | 2330 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1733 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2016 | 402 | 0.030 |
Why?
| | Recombination, Genetic | 1 | 2015 | 205 | 0.030 |
Why?
| | Protein Conformation | 1 | 2017 | 946 | 0.030 |
Why?
| | Rats, Wistar | 1 | 2015 | 451 | 0.030 |
Why?
| | Binding Sites | 1 | 2017 | 1331 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 1087 | 0.020 |
Why?
| | Amino Acids | 1 | 2017 | 522 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2016 | 744 | 0.020 |
Why?
| | Cell Line | 1 | 2019 | 2882 | 0.020 |
Why?
| | Software | 1 | 2019 | 692 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2925 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2017 | 1465 | 0.020 |
Why?
| | Basement Membrane | 1 | 2012 | 32 | 0.020 |
Why?
| | Lipids | 1 | 2017 | 710 | 0.020 |
Why?
| | Laminin | 1 | 2012 | 72 | 0.020 |
Why?
| | Protein Interaction Maps | 1 | 2012 | 51 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 475 | 0.020 |
Why?
| | Survival Rate | 1 | 2017 | 2092 | 0.020 |
Why?
| | Models, Molecular | 1 | 2017 | 1619 | 0.020 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 179 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2017 | 936 | 0.020 |
Why?
| | Embryo Culture Techniques | 1 | 2011 | 11 | 0.020 |
Why?
| | Extracellular Matrix Proteins | 1 | 2012 | 159 | 0.020 |
Why?
| | Haplotypes | 1 | 2012 | 490 | 0.020 |
Why?
| | Mothers | 1 | 2017 | 775 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2017 | 1167 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2017 | 1339 | 0.020 |
Why?
| | RNA | 1 | 2017 | 940 | 0.020 |
Why?
| | Mitochondria | 1 | 2017 | 984 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 331 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2021 | 4569 | 0.020 |
Why?
| | Chronic Disease | 1 | 2016 | 1813 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2011 | 454 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 8279 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 851 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2609 | 0.020 |
Why?
| | Time Factors | 1 | 2019 | 7183 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6053 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 2118 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2012 | 4155 | 0.010 |
Why?
| | Aged | 1 | 2023 | 25947 | 0.010 |
Why?
|
|
Vanderlinden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|